Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Merrimack Pharmaceuticals, Inc. (MACK)

« Back to company index

MACK Chatter Timeline

Stock Ticker for MACK

Most Active Tweeters for MACK

UserTweets
@Gambiste1 3
@itchibahn 2
@DFWCheapHouses 1
@SuicideSaint666 1

Recent Tweets for MACK

Gambiste1 @Gambiste1
RT @itchibahn: $MACK Interesting as there were no insider activity since 9/15/2017, and then suddenly they are buying in 2019. https://t.co…
June 14th 2019, 2:06pm
Gambiste1 @Gambiste1
RT @itchibahn: $MACK closed out Sep20 7.00 Covered Calls, +260% 4few months of hold but only 16 contracts.
June 14th 2019, 2:06pm
itchibahn @itchibahn
$MACK Interesting as there were no insider activity since 9/15/2017, and then suddenly they are buying in 2019. https://t.co/TKjNqVcZQa
June 14th 2019, 2:06pm
itchibahn @itchibahn
$MACK closed out Sep20 7.00 Covered Calls, +260% 4few months of hold but only 16 contracts.
June 14th 2019, 1:06pm
Gambiste1 @Gambiste1
RT @SuicideSaint666: I Woke Up In THe Morning, Bru$H My TeetH $mack My BitcH Ass.
June 7th 2019, 8:06am
SuicideSaint666 @SuicideSaint666
I Woke Up In THe Morning, Bru$H My TeetH $mack My BitcH Ass.
June 7th 2019, 3:06am
DFWCheapHouses @DFWCheapHouses
$MACK good volume today
June 5th 2019, 2:06pm
SweetNaeJones @SweetNaeJones
I’m old school . . . & I’ll $mack a bih
June 1st 2019, 5:06pm
mergerpie @mergerpie
Merrimack -2.6% as it decides against sale https://t.co/CwTnKs9fME $MACK
May 31st 2019, 8:05pm
ontargt @ontargt
Merrimack winding down operations $mack https://t.co/lwVCnhkSEm
May 31st 2019, 2:05pm
OpenOutcrier @OpenOutcrier
$MACK (-3.8% pre) Merrimack Pharma Announces Completion of Strategic Review, Preservation of Ipsen Milestones and S… https://t.co/hySXHkmntG
May 31st 2019, 8:05am
StockNewsWires @StockNewsWires
$MACK: Merrimack axes remaining staff, execs after selling assets to New …: https://t.co/ddKv3RzD7g
May 31st 2019, 6:05am
MarketChmln @MarketChmln
$MACK $MACK declines in after hours trading. See the latest news. https://t.co/JX5ozarAnY https://t.co/IqFLW0Jp1V
May 30th 2019, 7:05pm
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $MACK is $-1.36 it's -22.04% of the current price https://t.co/zk74RIE8x2
May 30th 2019, 5:05pm
newswithvalue @newswithvalue
$MACK: Merrimack -2.6% as it decides against sale: https://t.co/wmOrSayaeQ
May 30th 2019, 5:05pm
BosBizAllison @BosBizAllison
After shelving its sole drug candidate, @MerrimackPharma has ruled out a sale of the company. Background: https://t.co/sf7FTBmawG $MACK
May 30th 2019, 5:05pm
MarketCurrents @MarketCurrents
$MACK - Merrimack -2.6% as it decides against sale https://t.co/JPOxEw86QJ
May 30th 2019, 5:05pm
StockNewsNow @StockNewsNow
$MACK Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Spec… https://t.co/3NXTWgBU01
May 30th 2019, 5:05pm
pnani456 @pnani456
RT @TraderTexMex: $MACK negative news, management couldn't find any buyers for the company "determined not to move forward with any of them…
May 30th 2019, 4:05pm
TraderTexMex @TraderTexMex
$MACK negative news, management couldn't find any buyers for the company "determined not to move forward with any o… https://t.co/iqpa690g2l
May 30th 2019, 4:05pm
Stock_News_Now @Stock_News_Now
$MACK: New SEC Filing for MACK: Form 8-K (No. 0001193125-19-161299): https://t.co/QpzzVHY9XE
May 30th 2019, 4:05pm
fintel_io @fintel_io
Also, if you are new to $MACK here's some background for you https://t.co/oujiVpwJnQ
May 30th 2019, 4:05pm
confcalltran @confcalltran
Merrimack Pharmaceuticals Announces Completion Of Strategic Review, Preservation Of Ipsen https://t.co/jfTeu3Rx7Q $MACK
May 30th 2019, 4:05pm
MKsecalerts @MKsecalerts
$MACK - Current Report Filing (8-k) https://t.co/kVa7hqRo3s
May 30th 2019, 4:05pm
filingsdb @filingsdb
New Form 8-K filed by MERRIMACK PHARMACEUTICALS INC $MACK - https://t.co/oNjolawB9q
May 30th 2019, 4:05pm
NewsToDesk @NewsToDesk
$MACK: Merrimack Pharmaceuticals Announces Completion of Strategic …: https://t.co/3a4BGiQmbN
May 30th 2019, 4:05pm
ez_alertz @ez_alertz
$MACK Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Spec… https://t.co/CyQL4Vjnz9
May 30th 2019, 4:05pm
Allstocknews @Allstocknews
$MACK Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones an From our Stock News Alerts App
May 30th 2019, 4:05pm
MKsecalerts @MKsecalerts
$MACK - Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones https://t.co/mPYtMAsZ7c
May 30th 2019, 4:05pm
betrbiz @betrbiz
$MACK earnings tomorrow. Hate holding through earnings unless it's positive news then it's all good lol!
May 28th 2019, 6:05pm
bulletin_en @bulletin_en
Moderna Inc. $MACK Contrasting side by side https://t.co/mSHol2nhXY
May 23rd 2019, 2:05pm
bulletin_en @bulletin_en
Entera Bio Ltd. $MACK Contrasting side by side https://t.co/PiS2ElCSp0
May 23rd 2019, 8:05am
SwingTradeBot @SwingTradeBot
Recent $MACK technical alerts: Hammer Candlestick plus 6 more alerts... https://t.co/lR5hdjMVt5
May 21st 2019, 3:05pm
bulletin_en @bulletin_en
Aileron Therapeutics Inc. $MACK Comparing side by side https://t.co/euc1G5lpZu
May 21st 2019, 10:05am
FinZTribune @FinZTribune
Novo Nordisk A/S $MACK Contrasting side by side https://t.co/2le3rDGfEo
May 17th 2019, 7:05pm
fintel_io @fintel_io
Newtyn Management, LLC has filed an amended 13G/A, reporting 8.9% ownership in $MACK - https://t.co/YUCHHBdyxP
May 13th 2019, 4:05pm
Allstocknews @Allstocknews
$MACK New Form SC 13G/A for Merrimack Pharmaceuticals From our Stock News Alerts App
May 13th 2019, 4:05pm
ez_forms @ez_forms
$MACK Newtyn Management, LLC Discloses 8.9% Passive Ownership in MERRIMACK PHARMACEUTICALS INC Form: 13G/A Filing: https://t.co/FSFCgoz0XG
May 13th 2019, 4:05pm
Stock_News_Now @Stock_News_Now
$MACK: New SEC Filing for MACK: Form SC 13G/A (No. 0000905718-19-000433): https://t.co/XW3v4NiwE4
May 13th 2019, 4:05pm
MKsecalerts @MKsecalerts
$MACK - Amended Statement of Ownership (sc 13g/a) https://t.co/2cwPCxWtb6
May 13th 2019, 4:05pm
RoccoLefkowitz @RoccoLefkowitz
Covered all 2000 $MACK at 5.85 for profit of $700, seems to be holding steady in a sea of red.
May 13th 2019, 3:05pm
macondailynews @macondailynews
Merrimack Pharmaceuticals $MACK Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS https://t.co/s9EvhNh66m
May 12th 2019, 10:05am
TheMarketsDaily @TheMarketsDaily
Merrimack Pharmaceuticals $MACK Releases Quarterly Earnings Results https://t.co/Rzb9iP9jtk
May 11th 2019, 12:05pm
WeekHerald @WeekHerald
Merrimack Pharmaceuticals $MACK Announces Earnings Results https://t.co/tVSpmx2FXl
May 11th 2019, 11:05am
AmericanBanking @AmericanBanking
Merrimack Pharmaceuticals $MACK Issues Earnings Results, Beats Expectations By $0.14 EPS https://t.co/4GFoZnVe0o #stocks
May 11th 2019, 11:05am
StockNewsNow @StockNewsNow
$MACK Merrimack Reports First Quarter 2019 Financial Results https://t.co/HyhCHP79wT
May 10th 2019, 11:05am
Allstocknews @Allstocknews
$MACK New Form 10-Q for Merrimack Pharmaceuticals From our Stock News Alerts App
May 10th 2019, 8:05am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $MACK for you: 2.94% https://t.co/rerLbd8rQp
May 10th 2019, 8:05am
StockTexts @StockTexts
$MACK Merrimack Pharmaceuticals, Inc. SEC Filing: Form 10-Q https://t.co/SlKfRy6Qa3
May 10th 2019, 8:05am
MKsecalerts @MKsecalerts
$MACK - Quarterly Report (10-q) https://t.co/dgZHj0y0VR
May 10th 2019, 8:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.